NAC

Acetylcysteine is registered in Spain as a medicine, not as a food supplement: it is authorized as a mucolytic and as a hospital antidote for paracetamol poisoning. Those medical uses are outside the scope of this page.

This page describes the regulatory status in Spain and the EU. Acetylcysteine is not regulated the same way everywhere, so if you are reading from another country, check the rules that apply where you live.

What you will find here is what research has measured when NAC has been studied as a supplement: in which populations, at what doses, with what result and with what degree of certainty. Suplepedia describes what published studies say and does not recommend taking it.

If you are considering taking NAC, discuss it with your doctor or pharmacist. If you have asthma or a history of bronchospasm, that consultation is especially relevant: it is the only NAC safety signal with direct regulatory backing, and it is detailed in Precautions.

NAC is a modified version of cysteine, one of the amino acids you already get from food. The added acetyl group makes it more stable and easier to absorb than free cysteine.

Inside the cell, cysteine is the part in short supply for making glutathione, the main antioxidant the body produces on its own. Supplying cysteine makes it possible to make more glutathione. That is the whole mechanism, and every promise surrounding NAC comes out of it.

Acetylcysteine is used in Spain as a medicine in two authorized indications: as a mucolytic and as an antidote for paracetamol poisoning in the hospital setting. These are medical uses, with their own product information, their own doses and their own clinical supervision. We do not develop them here.

Official information on each product authorized in Spain is published by the AEMPS in its CIMA database.

In athletic performance, the Australian Institute of Sport places it in Group B: emerging evidence, use only under supervision in research or in scenarios managed case by case. The trials with oral capsules contradict one another. The only pattern that orders them is that the effect shows up in those who started with low glutathione, and not in those whose level was normal.

In aging and oxidative stress, the results usually cited come from GlyNAC, a combination of glycine and NAC that is not the same thing as NAC alone. Its own researchers hold that NAC by itself does not reproduce those results.

In cognition, no trial has been found showing an improvement in memory, attention or mental speed in healthy people.

Studies in patients, not in healthy people. NAC has also been tested in people with specific diagnoses, from trichotillomania to schizophrenia, in many cases added to their usual treatment and under medical supervision. The results are mixed. It is not an indication, it is not a regimen and it is not a reason to take NAC on your own.

The most frequent adverse effects are digestive: nausea, vomiting, diarrhea and abdominal pain. The molecule’s sulfur smell does not help either.